The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Brendan C. Visser
Hepatobiliary surgeon, Pancreatic surgeon, Surgical oncologist
Associate Professor of Surgery (General Surgery) at the Stanford University Medical Center
Bio:
Dr. Visser is a native of San Francisco, the youngest of eight children. He attended Deep Springs College in Eastern California and then went on to earn his BS at Cornell University in Ithaca NY. After receiving his MD degree at the University of California - San Francisco, he stayed at UCSF for his residency training in general surgery. He then completed specialized fellowship training in hepatobiliary and pancreatic surgery (also called HPB surgery) at the University of Edinburgh in Ediburgh, UK. Dr. Visser is board certified in general surgery by the American Board of Surgery. His principle practice is at Stanford Hospital and the Stanford Cancer Center, but he is also a staff surgeon at the Veterans Affairs Palo Alto Health Care System, serving our veteran patients.
Dr. Visser is actively involved in the General Surgery training program and is the program director for the Stanford Hepatopancreatobiliary (HPB) Surgery fellowship program. Dr. Visser was honored in 2011 with the John Collins Memorial Teaching Award, an annual faculty recognition selected by the entire body of general surgery residents. He also received the Best Rotation Award in 2015, which is selected by Stanford chief residents in general surgery. He is the Medical Director of the GI Cancer Care Program at the Stanford Cancer Center.
Dr. Visser is actively involved in the General Surgery training program and is the program director for the Stanford Hepatopancreatobiliary (HPB) Surgery fellowship program. Dr. Visser was honored in 2011 with the John Collins Memorial Teaching Award, an annual faculty recognition selected by the entire body of general surgery residents. He also received the Best Rotation Award in 2015, which is selected by Stanford chief residents in general surgery. He is the Medical Director of the GI Cancer Care Program at the Stanford Cancer Center.
- 875 Blake Wilbur Drive
- Palo Alto , CA 94304
- Phone: 650-498-6000
- 875 Blake Wilbur Drive
- Palo Alto , CA 94304
- Phone: 650-498-6000
- 420 Broadway Street, 2nd Floor
- Redwood City , CA 94063
- Phone: 650-736-5555
Practice Areas
Professional Education
- Residency: Univ of California San Francisco (2005) CA
- Medical Education: Univ of California San Francisco (1999) CA
- Fellowship: University of Edinburgh; Edinburgh Royal (2006)
- Board Certification: General Surgery, American Board of Surgery (2006)
- MD, Univ. of Calif., San Francisco, Medicine (1999)
- Resident, Univ. Of Calif., San Francisco, General Surgery (2005)
- Fellow, Univ. of Edinburgh, UK, Hepatobiliary/Pancreatic Surgery (2006)
Honors & Awards
- Best Rotation Award: Stanford Chief Residents 2015, Stanford General Surgery Residency (2014-2015)
- John Collins Memorial Teaching Award, Annual faculty teaching award selected by entire body of general surgery residents (2010-2011)
Administrative Appointments
- Medical Director, Gastrointestinal Cancer Care Program, Stanford Cancer Center (2015 - Present)
- Program Director, HPB Fellowship, Stanford HPB Program (2013 - Present)
Publications
-
Safety and timing of nonobstetric abdominal surgery in pregnancy
Visser, B. C., Glasgow, R. E., Mulvihill, K. K., & Mulvihill, S. J. (2001). Safety and timing of nonobstetric abdominal surgery in pregnancy. DIGESTIVE SURGERY, 18(5), 409–417. -
Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal
Visser, B. C., Venook, A. P., & Patti, M. G. (2003). Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. SURGICAL ONCOLOGY-OXFORD, 12(1), 1–7. -
Diagnostic imaging of cystic pancreatic neoplasms
Visser, B. C., Muthusamay, V. R., Mulvihill, S. J., & Coakley, F. (2004). Diagnostic imaging of cystic pancreatic neoplasms. SURGICAL ONCOLOGY-OXFORD, 13(1), 27–39. -
Congenital choledochal cysts in adults
Visser, B. C., Suh, I., Way, L. W., & Kang, S. M. (2004). Congenital choledochal cysts in adults. ARCHIVES OF SURGERY, 139(8), 855–860.
-
The influence of portoenterostomy on transplantation for biliary atresia
Visser, B. C., Suh, I., Hirose, S., Rosenthal, P., LEE, H., Roberts, J. P., & Hirose, R. (2004). The influence of portoenterostomy on transplantation for biliary atresia. LIVER TRANSPLANTATION, 10(10), 1279–1286.
-
Characterization of cystic pancreatic masses: Relative accuracy of CT and MRI
Visser, B. C., Yeh, B. M., Qayyum, A., Way, L. W., McCulloch, C. E., & Coakley, F. V. (2007). Characterization of cystic pancreatic masses: Relative accuracy of CT and MRI. AMERICAN JOURNAL OF ROENTGENOLOGY, 189(3), 648–656.
-
Open cholecystectomy in the laparoendoscopic era
Visser, B. C., Parks, R. W., & Garden, O. J. (2008). Open cholecystectomy in the laparoendoscopic era. AMERICAN JOURNAL OF SURGERY, 195(1), 108–114.
-
Diagnostic evaluation of cystic pancreatic lesions
Visser, B. C., Muthusamy, V. R., Yeh, B. M., Coakley, F. V., & Way, L. W. (2008). Diagnostic evaluation of cystic pancreatic lesions. HPB, 10(1), 63–69.
-
A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE CARNEY COMPLEX
Peck, M. C., Visser, B. C., Norton, J. A., Pasche, L., & Katznelson, L. (2010). A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE CARNEY COMPLEX. ENDOCRINE PRACTICE, 16(2), 198–204.
-
-
Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer
Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., … Chang, D. T. (2010). Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer. CANCER, 116(16), 3943–3952.
-
Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma
Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., Kunz, P., … Pai, R. K. (2010). Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma. CANCER, 116(22), 5179–5187.
-
Predictors of Surgical Intervention for Hepatocellular Carcinoma
Zak, Y., Rhoads, K. F., & Visser, B. C. (2011). Predictors of Surgical Intervention for Hepatocellular Carcinoma. ARCHIVES OF SURGERY, 146(7), 778–784.
-
Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy
Ghole, S. A., Bakhtary, S., Staudenmayer, K., Sze, D. Y., Pai, R. K., Visser, B. C., … Poultsides, G. A. (2011). Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy. DIGESTIVE DISEASES AND SCIENCES, 56(7), 1949–1953.
-
Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection
Norton, J. A., Harris, E. J., Chen, Y., Visser, B. C., Poultsides, G. A., Kunz, P. C., … Jensen, R. T. (2011). Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection. ARCHIVES OF SURGERY, 146(6), 724–732.
-
Adult Intestinal Malrotation: When Things Turn the Wrong Way
Palmer, O. P., Rhee, H. H., Park, W. G., & Visser, B. C. (2012). Adult Intestinal Malrotation: When Things Turn the Wrong Way. DIGESTIVE DISEASES AND SCIENCES, 57(2), 284–287.
-
Single-cell dissection of transcriptional heterogeneity in human colon tumors
Dalerba, P., Kalisky, T., Sahoo, D., Rajendran, P. S., Rothenberg, M. E., Leyrat, A. A., … Quake, S. R. (2011). Single-cell dissection of transcriptional heterogeneity in human colon tumors. NATURE BIOTECHNOLOGY, 29(12), 1120–U11.
-
Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema
Qadan, M., Visser, B., Kim, J., Pai, R., & Triadafilopoulos, G. (2012). Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema. DIGESTIVE DISEASES AND SCIENCES, 57(6), 1465–1468.
-
Sump Syndrome as a Complication of Choledochoduodenostomy
Qadan, M., Clarke, S., Morrow, E., Triadafilopoulos, G., & Visser, B. (2012). Sump Syndrome as a Complication of Choledochoduodenostomy. DIGESTIVE DISEASES AND SCIENCES, 57(8), 2011–15.
-
Video-assisted thoracoscopic transdiaphragmatic liver resection for hepatocellular carcinoma
Cloyd, J. M., & Visser, B. C. (2012). Video-assisted thoracoscopic transdiaphragmatic liver resection for hepatocellular carcinoma. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26(6), 1772–1776.
-
Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., Ford, J. M., … Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E595–E601.
-
-
Preoperative embolization of replaced right hepatic artery prior to pancreaticoduodenectomy
Cloyd, J. M., Chandra, V., Louie, J. D., Rao, S., & Visser, B. C. (2012). Preoperative embolization of replaced right hepatic artery prior to pancreaticoduodenectomy. JOURNAL OF SURGICAL ONCOLOGY, 106(4), 509–512.
-
-
Changes in spleen volume after resection of hepatic colorectal metastases
Jacobs, K. E., Visser, B. C., & Gayer, G. (2012). Changes in spleen volume after resection of hepatic colorectal metastases. CLINICAL RADIOLOGY, 67(10), 982–987.
-
The Epidemiology of Idiopathic Acute Pancreatitis, Analysis of the Nationwide Inpatient Sample From 1998 to 2007
Chen, Y., Zak, Y., Hernandez-Boussard, T., Park, W., & Visser, B. C. (2013). The Epidemiology of Idiopathic Acute Pancreatitis, Analysis of the Nationwide Inpatient Sample From 1998 to 2007. PANCREAS, 42(1), 1–5.
-
Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
Visser, B. C., Ma, Y., Zak, Y., Poultsides, G. A., Norton, J. A., & Rhoads, K. F. (2012). Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB, 14(8), 539–547.
-
Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
Krampitz, G. W., Norton, J. A., Poultsides, G. A., Visser, B. C., Sun, L., & Jensen, R. T. (2012). Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors. ARCHIVES OF SURGERY, 147(9), 820–827.
-
-
Neoadjuvant Imatinib for Borderline Resectable GIST
Koontz, M. Z., Visser, B. M., & Kunz, P. L. (2012). Neoadjuvant Imatinib for Borderline Resectable GIST. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(12), 1477–1482.
-
-
Complete resection of a rare intrahepatic variant of a choledochal cyst
Salles, A., Kastenberg, Z. J., Wall, J. K., Visser, B. C., & Bruzoni, M. (2013). Complete resection of a rare intrahepatic variant of a choledochal cyst. JOURNAL OF PEDIATRIC SURGERY, 48(3), 652–654.
-
-
-
Gallstone pancreatitis: why not cholecystectomy?
Worhunsky, D. J., & Visser, B. C. (2013). Gallstone pancreatitis: why not cholecystectomy? JAMA Surgery, 148(9), 872-?
-
Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.
Kin, C., Kidess, E., Poultsides, G. A., Visser, B. C., & Jeffrey, S. S. (2013). Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis. Expert Review of Molecular Diagnostics, 13(6), 581–599.
-
Development of a transillumination infrared modality for differential vasoactive optical imaging
Dixit, S. S., Kim, H., Visser, B., & Faris, G. W. (2009). Development of a transillumination infrared modality for differential vasoactive optical imaging. APPLIED OPTICS, 48(10), D178–D186.
-
-
Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program.
Cloyd, J. M., Ma, Y., Morton, J. M., Kurella Tamura, M., Poultsides, G. A., & Visser, B. C. (2014). Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program. Journal of Gastrointestinal Surgery , 18(3), 605–612.
-
-
Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy.
Cloyd, J. M., Kastenberg, Z. J., Visser, B. C., Poultsides, G. A., & Norton, J. A. (2014). Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy. Journal of Gastrointestinal Surgery , 18(2), 348–353.
-
Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation.
Huang, R. J., Visser, B. C., Chen, A. M., & Ladabaum, U. (2014). Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation. Digestive Diseases and Sciences, 59(2), 267–269.
-
Man with hypoechoic lesion abutting the pancreas.
Krampitz, G. W., Mills, A. M., & Visser, B. C. (2014). Man with hypoechoic lesion abutting the pancreas. JAMA Surgery, 149(4), 393–394.
-
Getting the dead out: modern treatment strategies for necrotizing pancreatitis.
Dua, M. M., Worhunsky, D. J., Amin, S., Louie, J. D., Park, W. G., Triadafilopoulos, G., & Visser, B. C. (2014). Getting the dead out: modern treatment strategies for necrotizing pancreatitis. Digestive Diseases and Sciences, 59(9), 2069–2075.
-
-
Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion.
Worhunsky, D. J., Zak, Y., Dua, M. M., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion. Journal of Gastrointestinal Surgery , 18(8), 1445–1451.
-
Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife
Dua, M. M., Qadan, M., Lutchman, G. A., Park, W. G., Triadafilopoulos, G., & Visser, B. C. (2015). Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife. DIGESTIVE DISEASES AND SCIENCES, 60(5), 1178–1182.
-
More with Less: Pancreas-Preserving Total Duodenectomy
Qadan, M., Dua, M., Worhunsky, D., Triadafilopoulos, G., & Visser, B. (2015). More with Less: Pancreas-Preserving Total Duodenectomy. DIGESTIVE DISEASES AND SCIENCES, 60(6), 1565–1568.
-
Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis
Worhunsky, D. J., Qadan, M., Dua, M. M., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 219(4), 735–743.
-
Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma.
Dua, M. M., Cloyd, J. M., Haddad, F., Beygui, R. E., Norton, J. A., & Visser, B. C. (2014). Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma. International Journal of Surgery Case Reports, 5(12), 927–931.
-
Extracorporeal Pringle for laparoscopic liver resection
Dua, M. M., Worhunsky, D. J., Hwa, K., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Extracorporeal Pringle for laparoscopic liver resection. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(6), 1348–1355.
-
-
Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion
Cloyd, J. M., Dua, M. M., & Visser, B. C. (2014). Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion. JOURNAL OF GASTROINTESTINAL SURGERY, 18(11), 2034–2037.
-
-
-
-
-
-
Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin?
Worhunsky, D. J., Gupta, M., Gholami, S., Tran, T. B., Ganjoo, K. N., van de Rijn, M., … Poultsides, G. A. (2015). Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin? JOURNAL OF SURGICAL ONCOLOGY, 111(7), 808–812.
-
-
Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma
Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. SURGERY, 158(2), 486–493.
-
-
-
Pancreatectomy with vein reconstruction: technique matters
Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB, 17(9), 824–831.
-
-
-
Pancreatectomy with vein reconstruction: technique matters.
Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB , 17(9), 824–831.
-
-
Stereotactic body radiation therapy and central liver toxicity: A case report.
Shaffer, J. L., Osmundson, E. C., Visser, B. C., Longacre, T. A., Koong, A. C., & Chang, D. T. (2015). Stereotactic body radiation therapy and central liver toxicity: A case report. Practical Radiation Oncology, 5(5), 282–285.
-
-
Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
Kozak, M. M., Anderson, E. M., von Eyben, R., Pai, J. S., Poultsides, G. A., Visser, B. C., … Chang, D. T. (2016). Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer. Pancreas, 45(1), 64–70.
-
Management of Postoperative Hepatic Failure
Qadan, M., Garden, O. J., Corvera, C. U., & Visser, B. C. (2016). Management of Postoperative Hepatic Failure. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 222(2), 195–208.
-
Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
Krampitz, G. W., George, B. M., Willingham, S. B., Volkmer, J.-P., Weiskopf, K., Jahchan, N., … Weissman, I. L. (2016). Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(16), 4464–69.
-
-
-
An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions?
Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions? AMERICAN JOURNAL OF SURGERY, 211(6), 991-?
-
The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample
Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(5), 1778–1783.
-
Biliary Cystadenoma: A Suggested "Cystamatic" Approach?
Dua, M. M., Gerry, J., Salles, A., Tran, T. B., Triadafilopoulos, G., & Visser, B. C. (2016). Biliary Cystadenoma: A Suggested "Cystamatic" Approach? DIGESTIVE DISEASES AND SCIENCES, 61(7), 1835–1838.
-
-
Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique.
Worhunsky, D. J., Dua, M. M., Tran, T. B., Siu, B., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique. Surgical Endoscopy, 30(10), 4307–4314.
-
-
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
Kidess-Sigal, E., Liu, H. E., Triboulet, M. M., Che, J., Ramani, V. C., Visser, B. C., … Jeffrey, S. S. (2016). Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. ONCOTARGET, 7(51), 85349–85364.
-
Recurrent Pyogenic Cholangitis: Got Stones?
Gholami, S., Wood, L., Berry, G., Triadafilopoulos, G., Visser, B. C., & Dua, M. M. (2016). Recurrent Pyogenic Cholangitis: Got Stones? Digestive Diseases and Sciences, 61(11), 3147–50.
-
Green Sludge: Intraductal Papillary Mucinous Neoplasm of the Bile Duct Presenting with Intermittent Biliary Obstruction Due to Abundant Mucus.
Choudhary, A., Barakat, M. T., Leal, J. N., Louie, C. Y., Visser, B. C., & Banerjee, S. (2016). Green Sludge: Intraductal Papillary Mucinous Neoplasm of the Bile Duct Presenting with Intermittent Biliary Obstruction Due to Abundant Mucus. Digestive Diseases and Sciences, -?
-
Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
Sighinolfi, M., Quan, S. Y., Lee, Y., Ibaseta, A., Pham, K., Dua, M. M., … Park, W. G. (2017). Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria. Digestive Diseases and Sciences, 62(3), 626–32.
-
-
Surgical Approaches to Chronic Pancreatitis: Indications and Techniques.
Dua, M. M., & Visser, B. C. (2017). Surgical Approaches to Chronic Pancreatitis: Indications and Techniques. Digestive Diseases and Sciences.
-
-
-
-
-
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, May 2018
There was some use of medical jargon for which I had to stop the provider and ask for a clarification.
SHC Patient, May 2018
Dr. Visser great clinician!
SHC Patient, Mar 2018
Excellent! Thank you!
SHC Patient, Jan 2018
This was just a short follow - up, that gave me confidence in my body's healing. Dr. Visser is a terrific physician & relates well to the patient.
SHC Patient, Jan 2018
All good.
SHC Patient, Jan 2018
care provider very easy to understand and very thorough
SHC Patient, Jan 2018
Excellent experience!
SHC Patient, Dec 2017
Surgeon was highly recommended to me by oncologist at PAMF. Nothing in subsequent appointments w/this doctor altered my impression of this surgeon.
SHC Patient, Dec 2017
I have total confidence in Dr. Visser. If I were asked where I wanted to go if I had to go the hospital; it would be Stanford.
SHC Patient, Oct 2017
My high marks are made without reservation. I cannot imagine better care from all levels. Thank you.
SHC Patient, Oct 2017
Always was put a ease. All test results were carefully explained. I always felt very good after each visit.
SHC Patient, Sep 2017
the information was both refreshing and a bit daunting as I have a rare problem and the surgeon recommended a second surgery to deal with the problem.
SHC Patient, Aug 2017
PA went over CT scans with us & explained very clearly.
SHC Patient, Jul 2017
Provider was just wonderful
SHC Patient, Jul 2017
Actual time spent with Dr. Visser helpful! Good explanations & answered all questions satisfactorily.
SHC Patient, Jun 2017
Thank you again!
SHC Patient, Jun 2017
no bad experience
SHC Patient, Mar 2017
I will gladly recommend both Dr. Visser and Dr. Heestand and their PA to Friends and Family
SHC Patient, Mar 2017
World's best doctor thank God for him.
SHC Patient, Jan 2017
Doctor was a bit distant, hurried, not engaged with me as an individual (but, not unusual for a surgeon).
SHC Patient, Jan 2017
Dr. Visser explained very clearly & answered all questions we had.
SHC Patient, Jan 2017
Always the best of care.
SHC Patient, Jan 2017
Dr Visser is a very nice man who can come down to your level and explain to you what he thinks. He is very good at being honest and providing you with any choice there may be. I liked his style very much. He knows people come to see him and they are nervous I believe Dr Visser realizes this and shows care and kindness yet he does give you the feeling he is very confidant but in a good way NOT an arrogant way.
SHC Patient, Nov 2016
Dr. Visser impresses me with his knowledge and expertise in his field. He makes me feel very comfortable and at easy when talking to him about my condition. He tends to explain things in easy to underst terms without feeling you are being talked down to.
SHC Patient, Oct 2016
Dr. Visser & his staff are awesome!
SHC Patient, Oct 2016
I consider Dr. Visser to be highly capable and kind. He has my utmost respect.
SHC Patient, Oct 2016
Dr. Visser carefully listened to my questions and gave complete and thoughtful answers.
SHC Patient, Oct 2016
Good experience.
SHC Patient, Sep 2016
Dr. Visser explained everything.
SHC Patient, Jul 2016
All are special, make me feel very good.
SHC Patient, Jul 2016
excellent!!!!
SHC Patient, Jun 2016
Dr. Visser listened carefully, explained what was going to happen in my surgery, and answered every question I asked.
SHC Patient, Apr 2016
Dr. Visser is the best!! Exceeds expectations! Friendly, knowledgeable, concerned. I tell everyone how wonderful he is.
SHC Patient, Apr 2016
All the doctors and nurses and people from the office and they are very friendly and attentive.
SHC Patient, Apr 2016
I feel very lucky to have Dr Visser and his staff as my health providers for my recent surgery.
SHC Patient, Apr 2016
I dont have any words to explain the level of care that my doctor has provided me. Its top notch..five star.
SHC Patient, Mar 2016
Dr. Visser saved my life. I went months of tests surgical procedures at Sutter Medical and not one doctor knew what was wrong. I had a death sentence until I found Dr. Visser.
SHC Patient, Feb 2016
I feel that I am in very competent hands and could not ask for more.
SHC Patient, Jan 2016
Dr. Visser highly experienced doctor. Very courteous, politeness, friendliness. I never see doctor like dr. Visser in my life. God will give long life.
SHC Patient, Jan 2016
Excellence.
SHC Patient, Nov 2015
Good
SHC Patient, Oct 2015
Dr. Visser was the first professional after seeing many doctors that came in and told me exactly what my health issue was and how to proceed. He explained every detail of what needed to be done leading up to my surgery in preparation to the details of the surgery. Dr. Visser takes his time and explains everything in a way that a person who is not a doctor can understand. he cares about his patients and his work.
SHC Patient, Aug 2015
I get respect and kindness there.
SHC Patient, Jul 2015
My husband and I felt like members of the treatment team and that we participated in determining the treatment plan. I wasn't told, this is what we are going to do.
SHC Patient, Jul 2015
Excellent.
SHC Patient, Jun 2015
Dr. Visser & Dr. Kunz were prepared, direct and knowledgeable. Excellent experience.
SHC Patient, Jun 2015
Good experience in everything.
SHC Patient, Jun 2015
Highly recommend Dr. Visser to any friends/family.
SHC Patient, May 2015
Dr. Visser is the best!!! I completely trust him.
SHC Patient, Apr 2015
I was more relaxed after speaking with the doctor.
SHC Patient, Mar 2015
Provider was very knowledgeable and answered all questions.
SHC Patient, Mar 2015
Both the NP & Dr. Visser were very thorough & made me feel comfortable.
SHC Patient, Mar 2015
Outstanding.
SHC Patient, Feb 2015
Visser is an outstanding surgeon! Never had to take pain medications.
SHC Patient, Jan 2015
Excellent saved my life.
SHC Patient, Nov 2014
Dr. Visser was excellent. Worth waiting for.
SHC Patient, Oct 2014
Good care was provided.
SHC Patient, Sep 2014
I consulted w/Dr. Visser briefly for a second opinion; he was professional - but brief - I decided to go elsewhere for my care -
SHC Patient, Aug 2014
He is very knowledgeable, very personable & confidence puts you @ ease. Might be helpful to check in with patient before or after surgery.
SHC Patient, Jul 2014
All good.
SHC Patient, Jul 2014
I feel as if I am in great hands with Dr. Visser.
SHC Patient, Jul 2014
Dr. Visser & his PA and all are Life savers and awesome.
SHC Patient, Jun 2014
PA was very good. Vissar is great once he arrived.
SHC Patient, May 2014
I appreciate my care provider, Dr. Brendan Visser. The way I look at him, he is sincere, kind and understanding.
SHC Patient, May 2014
Dr Visser was so good, friendly knowledgeable and reassuring.
SHC Patient, May 2014
I am not sure how I feel about this provider. I have had less than 15 minutes of interaction with them it is hard to determine how I feel.
SHC Patient, Mar 2014
My experience was comfortable with the provider & his staff.
SHC Patient, Jan 2014
Great dr. I will recommend.
SHC Patient, Jan 2014
Great doctor! Given encouragements & hope which are importance during difficult time & recovery.
SHC Patient, May 2018
There was some use of medical jargon for which I had to stop the provider and ask for a clarification.
SHC Patient, May 2018
Dr. Visser great clinician!
SHC Patient, Mar 2018
Excellent! Thank you!
SHC Patient, Jan 2018
This was just a short follow - up, that gave me confidence in my body's healing. Dr. Visser is a terrific physician & relates well to the patient.
SHC Patient, Jan 2018
All good.
SHC Patient, Jan 2018
care provider very easy to understand and very thorough
SHC Patient, Jan 2018
Excellent experience!
SHC Patient, Dec 2017
Surgeon was highly recommended to me by oncologist at PAMF. Nothing in subsequent appointments w/this doctor altered my impression of this surgeon.
SHC Patient, Dec 2017
I have total confidence in Dr. Visser. If I were asked where I wanted to go if I had to go the hospital; it would be Stanford.
SHC Patient, Oct 2017
My high marks are made without reservation. I cannot imagine better care from all levels. Thank you.
SHC Patient, Oct 2017
Always was put a ease. All test results were carefully explained. I always felt very good after each visit.
SHC Patient, Sep 2017
the information was both refreshing and a bit daunting as I have a rare problem and the surgeon recommended a second surgery to deal with the problem.
View All 69 Patient Comments »